Bristol Myers Squibb (BMS) has shared positive overall survival (OS) results from a late-stage study of its Opdivo (nivolumab ...

The European Commission (EC) has approved Biocon Biologics’ Yesintek, an ustekinumab biosimilar referencing Johnson & Johnson’s Stelara, to treat multiple inflammatory diseases.

Leadership is about more than guidance—it's about vulnerability. Learn how being genuine and approachable can foster trust ...

In today’s world, consumers expect seamless, engaging experiences at every touchpoint – from discovery to decision. Yet, when ...